Varanakis Ann 4
4 · LifeStance Health Group, Inc. · Filed Mar 9, 2026
Research Summary
AI-generated summary of this filing
LifeStance (LFST) CPO Ann Varanakis Receives 86,331 RSUs
What Happened
Ann Varanakis, Chief People Officer of LifeStance Health Group (LFST), was granted 86,331 restricted stock units (RSUs) on March 5, 2026 (transaction code A). The RSUs vested/settled on March 6, 2026 and 21,566 shares were withheld by the company to satisfy tax withholding obligations at $6.93 per share (transaction code F), a withholding value of approximately $149,452. The grant itself shows $0.00 as the acquisition price because RSUs represent contingent rights to receive shares rather than a cash purchase.
Key Details
- Grant date: March 5, 2026 — 86,331 RSUs granted (each RSU = right to one share). (Footnote F1)
- Settlement/withholding: March 6, 2026 — 21,566 shares withheld at $6.93 each to cover taxes (total ≈ $149,452). These withheld shares reduce the number of shares issued on settlement and are not an open‑market sale. (Footnote F2)
- Filing: Form 4 filed March 9, 2026; filing appears timely for the reported transaction dates.
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Transaction codes: A = Award/Grant; F = Tax withholding (not a public sale).
Context
RSU grants are compensation, not an outright purchase or market sale; they typically reflect retention/compensation rather than an investment signal. The withholding was a mechanical tax settlement (net settlement) rather than a public sale of shares, so it should not be interpreted as an executive selling stock on the open market.
Insider Transaction Report
- Award
Common Stock
[F1]2026-03-05+86,331→ 401,941 total - Tax Payment
Common Stock
[F2]2026-03-06$6.93/sh−21,566$149,452→ 380,375 total
Footnotes (2)
- [F1]Includes 86,331 restricted stock units ("RSUs") granted on March 5, 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on March 6, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.